Clinical Trial Update: Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)

View source ↗

Summary

A completed post-marketing surveillance study assessing MicardisPlus (telmisartan/hydrochlorothiazide) for morning hypertension using patient self-monitoring of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• MicardisPlus (telmisartan/hydrochlorothiazide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Status: COMPLETED